Feeds Biotechnologie

Technique may enable speedy, on-demand design of softer, safer neural devices.

A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic.

Repurposing a drug used for blood clots may help Covid-19 patients in danger of respiratory failure, researchers suggest.

An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.

Lincoln Laboratory researchers explore the impact of technology that detects a person's exposure to disease-causing pathogens before symptoms manifest.

Entrepreneurial science award recognizes scientists whose work opens up “new dimensions of economic progress."

A new approach reveals how different tissues contribute to inflammatory diseases such as ulcerative colitis.

Molecular biology researcher and MIT alumna is an Office of Engineering Outreach Programs (OEOP) instructor.

A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.

Device made of heart tissue and a robotic pumping system beats like the real thing.

Device developed within the Department of Civil and Environmental Engineering has the potential to replace damaged organs with lab-grown ones.

Study suggests noninvasive spectroscopy could be used to monitor blood glucose levels.

Managing her own synthetic biology project helped graduate student Jesse Tordoff overcome imposter syndrome and hit her stride.

Voigt Lab's work could eventually replace cereal crops’ need for nitrogen from chemical fertilizers.

A key part of J-Clinic, the MIT-Takeda Program will create educational opportunities and support cutting-edge research to positively impact human health.

Using specialized liver cells, a new test can quickly detect potentially cancer-causing DNA damage.

Talya Klinger and Steven Truong will begin graduate studies in the UK next fall.

Chemical engineers program bacteria to switch between different metabolic pathways, boosting their yield of desirable products.

Faculty members recognized for excellence via a diverse array of honors, grants, and prizes over the last quarter.

Baggeroer, Flynn, Harris, Klopfer, Lauffenburger, and Leonard are recognized for their efforts to advance science.

Film looks at how Kendall Square became a beacon for industries working on treatments for diseases like cancer, Alzheimer’s, and diabetes.

Team of researchers including MIT Professor Angela Koehler obtains $5.8 million grant to study fusion-positive alveolar rhabdomyosarcoma.

MIT students from the fields of bioengineering, business, computer science, and energy science receive the prestigious awards.

At the sixth annual Mechanical Engineering Research Exhibition, graduate students and postdocs sharpen their communication and presentation skills.

Award will support interdisciplinary research on the role of the human microbiome in health and disease.

James Collins, Pablo Jarillo-Herrero, and Richard Milner have won top prizes for their work.

Engineered signaling pathways could offer a new way to build synthetic biology circuits.

Study shows tumors with softer, larger cells at their periphery are more likely to spread; may suggest new route for cancer therapy.

His technology platforms have benefited genomics, diagnostics, and drug screening.

New image-based genetic screening method helps researchers identify key regulators of inflammation.

Specialized sugar molecules called glycans can disarm opportunistic pathogens and prevent infection.

Fluorescent probe could allow scientists to watch circuits within the brain and link their activity to specific behaviors.

SMART has developed a new way to study cells, paving the way for a better understanding of how cancers spread and become deadly.

Testing platform will allow the research community to explore the human microbiome in new ways.

By tweaking bacteriophage genomes, MIT team creates a new weapon to combat infection.

Rapid imaging method could help reveal how conditions such as autism affect brain cells.

Researchers identify nearly 8,000 strains of bacteria, while also clarifying their genetic and metabolic context.

Magnetically controlled device could deliver clot-reducing therapies in response to stroke or other brain blockages.

Smart materials change properties in response to specific DNA sequences; could be used in a variety of devices.

Engineers program human and bacterial cells to keep a record of complex molecular events.

Study finds that Alzheimer’s damage allows toxins to enter the brain, further harming neurons.

Shining light through household bleach creates fluorescent quantum defects in carbon nanotubes for quantum computing and biomedical imaging.

Researchers from MIT's Koch Institute will work with teams in the UK and Europe to use nanoparticles to carry multiple drug therapies to treat glioblastoma.

A new dosing regimen for an old cancer drug shows new promise as an immunotherapy.

The new system, dubbed RESCUE, allows RNA edits to be made that were not previously possible.

Super-charging a treatment for leukemia also makes it effective on solid tumors.

Two drugs that block cell division synergize to kill tumor cells.

Attaching a Velcro-like molecule may prevent immune proteins called cytokines from leaking out of cancerous tissue after injection.

Developed at MIT Lincoln Laboratory, IdPrism and its award-winning algorithms provide rapid analysis for complex forensic DNA samples.

MIT PhD and MBA students proposed a winning solution for sustainable food and apparel packaging.